Sign in Create account

Indegene Limited

Healthcare · Healthcare Services

NSE: INDGN BSE: 544172
₹590.75
▼ -14.40 (-2.38%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
83/100
Strong
Valuation
10/100
Expensive
Momentum
51/100
Neutral

QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

About

Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics.

Source: Wikipedia

Key Metrics

Market Capitalization
₹14,234 Cr
PE (TTM)
62.6
Industry median 50.2 (44 companies)
Price to Book
4.5
PEG (TTM)
3.8
Institutions holding %
18.65%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
19.3
Relative return vs Sector, qtr %
17.8
Free Cash Flow
₹606 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
32.45%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
16.86%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
19.71%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
32.82%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
33.29%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
2.41
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
32.43
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
17.58%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
24.27%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
23.84%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
8.68%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
15.40%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
12.78%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

5 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (12.8%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.4%
Low 585.0000 · High 614.5000
1W return
-1.3%
Low 585.0000 · High 627.0000
1M return
-3.4%
Low 559.0000 · High 627.0000
52W return
4.4%
Low 414.0000 · High 627.0000
Lifetime High ₹732.7000 (Oct. 1, 2024)
Lifetime Low ₹423.5000 (March 23, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
599.7
10D
597.7
20D
591.8
50D
571.9
100D
549.5
200D
515.7

Delivery and volume

Day avg. delivery
45.1%
Week avg. delivery
40.5%
Month avg. delivery
53.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

596.75
Pivot
First resistance608.50
Second resistance626.25
Third resistance638.00
First support579.00
Second support567.25
Third support549.50
Day RSI51.9
Day MFI54.7
Day MACD8.84
Day MACD signal9.53

Beta

1M0.84
3M0.90
1Y0.81
3Y0.86

Price change analysis

↓ -3.4%
Over 1 Month
LowHigh
559.00627.00
↑ 15.0%
Over 3 Months
LowHigh
481.95627.00
↑ 27.2%
Over 6 Months
LowHigh
448.15627.00
↑ 4.4%
Over 1 Year
LowHigh
414.00627.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 62.6 (own history: 49.2–79.6)
Fair Value Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹341 Cr
Net profit (June 30, 2026)
₹60 Cr
Basic EPS (June 30, 2026)
₹2.4900

Ranks #12 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Mutual funds5.28%
  • FII/FPI9.91%
  • Other DII3.46%
  • Public81.35%

Largest holders

NameCategoryShares %Shares
Nadathur Fareast Pte LtdPublic21.8700%52700256
Manish GuptaPublic8.9100%21474076
Rajesh Bhaskaran NairPublic7.1400%17201536
Bpc Genesis Fund I Spv LtdPublic5.7500%13862223
Sanjay S ParikhPublic4.9800%12008172

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Historical fii holding

FII/FPI holdings decreased from 10.27% to 9.91% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 4.70% to 5.28% in Jun 2026 qtr

22 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 21 insider trades, 13 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
24 Mar 2026 Anita Nair Immediate relative Buy 0 ₹0
4 Mar 2026 Sameer Narendrakumar Lal Other Sell 0 ₹0
18 Nov 2025 Sameer Narendra Lal Other Sell 0 ₹0
14 Nov 2025 AMIT GUPTA Other Sell 0 ₹0
14 Nov 2025 AMIT GUPTA Other Sell 0 ₹0
14 Nov 2025 AMIT GUPTA Other Sell 0 ₹0
14 Nov 2025 BINA PATIL Other Sell 0 ₹0
14 Nov 2025 BINA PATIL Other Sell 0 ₹0
14 Nov 2025 BINA PATIL Other Sell 0 ₹0
14 Nov 2025 BINA PATIL Other Sell 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 35 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
6 Aug 2026 QUANT MUTUAL FUND Block Buy 9,523,810 525.0000 NSE
6 Aug 2026 NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL Block Buy 480,000 525.0000 NSE
6 Aug 2026 MORGAN STANLEY ASIA SINGAPORE PTE Block Buy 665,048 525.0000 NSE
6 Aug 2026 ICICI PRUDENTIAL MUTUAL FUND Block Buy 6,767,239 525.0000 NSE
6 Aug 2026 GOLDMAN SACHS INVESTMENTS MAURITIUS I LIMITED Block Buy 477,000 525.0000 NSE
6 Aug 2026 CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED Block Buy 477,000 525.0000 NSE
6 Aug 2026 BUOYANT OPPORTUNITIES STRATEGY-III Block Buy 480,000 525.0000 NSE
6 Aug 2026 BUOYANT OPPORTUNITIES STRATEGY - II Block Buy 480,000 525.0000 NSE
6 Aug 2026 BPC GENESIS FUND I-A SPV LIMITED Block Sell 7,190,255 525.0000 NSE
6 Aug 2026 BPC GENESIS FUND I SPV LIMITED Block Sell 13,862,223 525.0000 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹2.25 per share
Dividend yield 0.38%
Ex-dateSubjectPer share (₹)Record date
31 Jul 2026 Dividend - Rs 2.25 Per Share 2.2500 31 Jul 2026
13 Jun 2025 Dividend - Rs 2 Per Share 2.0000 13 Jun 2025

Corporate Actions

Full history (3 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
29 Aug 2024OTHERAnnual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
30 Jul 2026 Financial Results Yes
29 Apr 2026 Financial Results/Dividend Yes
29 Jan 2026 Financial Results Yes
30 Oct 2025 Financial Results Yes
28 Apr 2025 Financial Results/Dividend Yes

Corporate Announcements

All 317 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Board Meeting Indegene Ltd - 544172 - Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026 Along With The Limited Review Report Of The Auditors Thereon.
30 Sep 2026 Company Update Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Indegene Limited has informed the Exchange about Schedule of meet
28 Sep 2026 Insider Trading / SAST Indegene Ltd - 544172 - Closure of Trading Window
28 Sep 2026 Trading Window Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
23 Sep 2026 Press Release Indegene Limited has informed the Exchange regarding a press release dated September 23, 2026, titled "From Promise to Performance: Life Sciences Leaders Focus on Operationalizing AI to Deliver Enterprise Outcomes at Indegene Digital Summit 2026".
10 Sep 2026 Company Update Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Restructuring
10 Sep 2026 Amalgamation/Merger Indegene Limited has informed the Exchange about Amalgamation/Merger of Indirect Wholly Owned Subsidiaries of the Company in Germany
8 Sep 2026 Company Update Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Indegene Limited has informed the Exchange about Schedule of meet

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (32.4x)
  • Healthy liquidity (Current Ratio 2.41)
  • Strong revenue growth YoY (33.3%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (62.6) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Part of: NIFTY 500

Frequently asked questions about Indegene Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.